[1]
N. authors, “UK Kidney Association Clinical Practice Guideline: Sodium-Glucose Co-transporter-2 (SGLT-2) Inhibition in Adults with Kidney Disease”, KIDNEYS, vol. 11, no. 1, pp. 30–36, May 2022.